0001242616-12-000017.txt : 20120807
0001242616-12-000017.hdr.sgml : 20120807
20120807161317
ACCESSION NUMBER: 0001242616-12-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120806
FILED AS OF DATE: 20120807
DATE AS OF CHANGE: 20120807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLEN LEE F MD PhD
CENTRAL INDEX KEY: 0001408474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 121013392
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2012-08-06
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001408474
ALLEN LEE F MD PhD
C/O AMAG PHARMACEUTICALS, INC.
100 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
EVP, Chief Medical Officer
Common Stock
2012-08-06
4
C
0
5000
A
7229
D
Common Stock
2012-08-06
4
S
0
5000
A
2229
D
Restricted Stock Unit
2012-08-06
4
C
0
5000
A
Common Stock
5000
5000
D
The shares were acquired by the reporting person as a result of the partial vesting of a restricted stock unit grant described below.
Not applicable.
The shares sold on this date were sold in multiple transactions. The actual sales prices range from $15.67-$15.745. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
Each restricted stock unit represents a contingent right to receive one share of common stock.
Grant of 20,000 restricted stock units pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant vested as follows: 50% on August 5, 2010, 25% on August 5, 2011 and the remaining 25% on August 5, 2012.
Nancy R. Smith, attorney-in-fact
2012-08-07